Objective: To analyze operative repair, extracorporeal membrane oxygenation (ECMO) and survival rates based on highest pre-ductal oxygen saturation (Pre-O 2 SAT) in a large infant cohort reported to Congenital Diaphragmatic Hernia Study Group Registry between 2000 and 2010.
Introduction
Congenital diaphragmatic hernia (CDH) is one of the most common serious congenital anomalies managed in the newborn intensive care unit, occurring in B1 per 2500 births.
1-3 Despite many technological advances over the past two decades, including high frequency ventilation, inhaled nitric oxide, surfactant replacement therapy and extracorporeal membrane oxygenation (ECMO), CDH continues to be associated with relatively high rates of mortality and morbidity. Over the past decade, reported overall survival rates within the Congenital Diaphragmatic Hernia Study Group (CDHSG) Registry have consistently remained between 70 and 72%.
Efforts to minimize futile intervention and optimize resource utilization have led some centers to establish clinical guidelines recommending no ECMO and no surgical intervention if pre-ductal oxygen saturations (Pre-O 2 SAT) cannot be achieved above a limited value, most often 85%. [4] [5] [6] [7] Other centers have suggested that all infants with CDH should be potential operative candidates regardless of their oxygenation state. [8] [9] [10] Published reports contrasting the outcomes associated with either approach are lacking.
The purpose of this study is to determine the predictive value of the highest reported Pre-O 2 SAT during the first 24 h of life, or before ECMO, of infants born with CDH. The hypothesis of this study is that a highest Pre-O 2 SAT <85% is incompatible with survival and that operative repair and/or ECMO intervention does not affect the outcome.
Methods
The CDHSG was formed in 1995 to compile data on live-born neonates with CDH to allow assessment of therapies and outcome. Data are collected from participating centers on all inborn or transferred infants with CDH. The CDHSG is a voluntary collaboration of international tertiary referral centers providing care for CDH patients who provide data to a central registry. 11 The CDHSG Registry was approved by the University of Texas School of Medicine at Houston Institutional Review Board (HSC-MS-03-223). Participating centers filed a waiver of consent for data submission or signed a data use agreement for a limited data set. Data include information on delivery and subsequent hospitalization until death or discharge. Because of the registry nature of the data, patients in the CDH Registry may not have complete data for all variables.
We retrospectively reviewed data from all CDH infants enrolled in the CDHSG database from 01/2000 to 12/2010. The following recorded variables were used: (1) gender, (2) gestational age in weeks, (3) birth weight in kilograms, (4) type and severity of associated anomalies, (5) position of CDH (left, right, bilateral or central), (6) CDH repair (yes/no), (7) reason given for non-repair, (8) type of repair (primary/patch), (9) use of ECMO, (10) patient disposition (discharge, death or transfer), (11) age at discharge or death and (12) measurements of oxygenation and ventilation in the initial 24 h of life or before initiation of ECMO.
Lung function, as measured by oxygenation and ventilation, was assessed in several ways. For the primary outcome, we analyzed the reported data for the highest Pre-O 2 SAT using the following groupings: <85%, 85 to 89%, 90 to 93%, 94 to 98% and X99%. Secondary analyses were performed using the highest reported data for PaO 2 (either pre-ductal or post-ductal), the highest and lowest PaCO 2 , and the Wilford Hall Santa Rosa score (derived as previously described by Schultz et al. 12 ) by subtracting the highest measured PaCO 2 from the highest measured PaO 2 during the first 24 h of life or before ECMO support.
The primary outcome for this study was survival based on the reported highest Pre-O 2 SAT. Based on the previous recommendations from the literature and our internal data, we hypothesized that no infants with a maximum Pre-O 2 SAT<85% would survive regardless of ECMO support or operative repair. Comparisons were made between Pre-O 2 SAT groups by w 2 analysis for categorical data and one-way analysis of variance or KruskalWallis for continuous data as appropriate. Variables affecting mortality from univariate analysis that were statistically significant at P<0.05 were included in multivariate regression analysis for survival outcome. All analyses were performed using SPSS version 19 (IBM, Armonk, NY, USA).
Results
The initial data set included 4434 infants. Survival of the entire study cohort was 70% (3113/4434). Infants with severe anomalies had significantly lower survival (40 versus 75%, P<0.001) and were significantly more likely to have low Pre-O 2 SAT values (29% of all infants <90% versus 9% of all infants X99%, P<0.001). Therefore, we excluded 618 infants with severe anomaly defined as major cardiac anomaly (n ¼ 354), chromosomal disorders (n ¼ 198) and other major organ defects (n ¼ 86) from further analysis. After exclusion for severe anomaly, survival was 75% (2866/3816). Of the remaining 3816 infants, 1672 had a reported highest Pre-O 2 SAT value and 2857 had a reported maximum PaO 2 value, either pre-ductal (n ¼ 774) or post-ductal (n ¼ 2083). Survival for infants in each of these smaller cohorts remained at 75%.
Demographic data for the defined Pre-O 2 SAT groups are shown in Table 1 . A highest Pre-O 2 SAT<85 was reported for 6.3% of the study group; and a value <90% was reported for 8.8%. Although no difference was found for gestational age, the highest Pre-O 2 SAT group (X99%) was significantly heavier at birth than the two lowest groups. As expected, indicators suggesting more severe diaphragmatic hernia including right-sided hernia, use of patch for repair and ECMO support were significantly increased as the highest Pre-O 2 SAT group values decreased. Operative repair was significantly more frequent as Pre-O 2 SAT values increased, going from only 52% when highest Pre-O 2 SAT was <85%, to >90% when highest Pre-O 2 SAT was X99% (P<0.001). Overall survival decreased dramatically as highest Pre-O 2 SAT values decreased (Table 1; Figure 1 ). Not only was ECMO used more frequently as highest Pre-O 2 SAT values decreased (Table 1) , but survival was increasingly dependent on the use of ECMO support as these values decreased ( Figure 2 ).
Contrary to our hypothesis, we found that a highest Pre-O 2 SAT value <85% was not universally fatal as overall survival of infants in this saturation range was 23%. Importantly, the survival rate increased to 44% if operative repair was performed (Figure 1 ). The reason for non-repair has only been recorded on the Registry data form since 2007. The most common reported reasons for no Table 1 Demographic and outcome data for infants with congenital diaphragmatic hernia by reported highest pre-ductal O 2 saturation group (severe anomaly excluded) Among infants with a highest Pre-O 2 SAT <90%, a small group had potentially conflicting oxygenation data within the data set. In all, 10 of 105 (10%) infants with highest Pre-O 2 SAT <85% had either a reported pre-or post-ductal PaO 2 value X60 mm Hg (n ¼ 8) and/or a post-ductal O 2 saturation X90% (n ¼ 5), whereas almost one third (14/42) of the infants with a highest Pre-O 2 SAT 85 to 89% had potential conflicting oxygenation data. Analysis of this subgroup is shown in Table 3 . Despite these potential conflicts, the rates for operative repair, patch repair, ECMO support and survival were the same for this small subgroup of infants as for the groups as a whole.
Evaluation of other markers for oxygenation or ventilation demonstrated similar trends for survival: decreased as the highest PaO 2 value decreased, decreased as the lowest value for PaCO 2 increased, and decreased as the Wilford Hall Santa Rosa score decreased (Figure 3a-c) . No identifiable cutoff value could be determined for any of these risk markers that could achieve positive or negative predictive values of >90% ( Table 2 ). The highest negative predictive value (predicting survival if risk factor not present) was for Wilford Hall Santa Rosa score X0 (88%); the best positive predictive value (predicting death if risk factor present) was for the combination of highest Pre-O 2 SAT <85 plus lowest PaCO 2 X70 (88%). However, <1% of infants fell into this latter risk group. In our registry data set, there were 490 ECMO supported infants with reported lowest PaCO 2 values. Among this group, survival was equivalent for lowest PaCO 2 <50 (173/317; 55%) compared with lowest PaCO 2 value >70 (39/74; 53%). Regression modeling identified four factors contributing to increased risk for death, including ECMO support, patch repair, Wilford Hall Santa Rosa score <0 and highest Pre-O 2 SAT<85% (Table 4) .
Discussion
CDH remains a serious anomaly with a relatively high mortality that has not significantly changed over the past decade. Associated major cardiac anomalies, chromosomal disorders and other serious anomalies convey a markedly higher mortality risk compared with infants with an isolated CDH or with only a minor associated anomaly. 3, 13, 14 In this large cohort study of infants without severe anomaly from the CDHSG Registry, we determined that failure to achieve a pre-ductal saturation value >85% is not necessarily fatal. Moreover, we found that intervening in this group of infants with more aggressive support, including ECMO and operative repair, was associated with a doubling of the survival rate. The 44% survival rate in repaired infants with a highest Pre-O 2 SAT <85% stands in marked contrast to universally fatal outcome for all unrepaired infants in the registry with a highest Pre-O 2 SAT p93% (0/146). Our findings suggest that recommendations to minimize operative and ECMO intervention if specified minimum Pre-O 2 SAT values cannot be achieved may result in unnecessary deaths. Not surprisingly, infants with a highest Pre-O 2 SAT <85% represented a high-risk group of patients. Among those undergoing repair, patch repair was performed in all but two (96%). Over 80% of survivors received ECMO support, and survivors were hospitalized for significantly longer periods of time and had higher rates of discharge on oxygen. Given these factors, the cost per patient survival is likely much higher for infants with CDH and a highest Pre-O 2 SAT value <85%; 15 however, they represent a relatively small proportion of all CDH infants (6% of all study infants and <4% of those undergoing repair), so the contribution to overall initial hospital costs is relatively low. Neither a cost analysis nor longterm follow-up of this group of infants was available for this study. Differences between groups for all comparisons were significant at P<0.001. we did not find the lowest PaCO 2 value a better marker of survival for either the total cohort, those infants undergoing repair or those infants who were managed on ECMO. In their report of 62 CDH infants managed on ECMO between 1993 and 2007, survival with a lowest pre-ECMO PaCO 2 >70 mm Hg was 0% compared with 56% if lowest PaCO 2 was <50 mm Hg. They did not provide the specific number of patients that fell into this group, nor did they present data on predictive discrimination. The multicenter makeup of the CDHSG Registry, the much larger data set and exclusion of infants managed before 2001 are important differences between our study and that of Hoffman et al. Over the past decade, there has been increasing acceptance of strategies aimed at minimizing ventilator induced lung injury, including acceptance of relative hypercapnia. 7, 8, 16 Available data does not allow us to determine the potential roles of less aggressive ventilation and timing of initial ECMO support among Registry centers. It should be noted, however, that none of the risk factors we assessed were independently predictive of survival for infants managed on ECMO.
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Limitations of this study predominantly lie in the nature of registry data, and, as with all outcome studies of CDH, data from the CHDSG Registry must be used with caution. There is heterogeneity of disease severity within and between institutions, as well as variation in the approach to CDH management including ventilator approach, pulmonary vasodilator support and approach to surgical repair.
Importantly, data submitted to the CDHSG Registry are not available for secondary review due to the limited data use agreements between contributing centers and the Registry data center.
In all data sets, there is potential for errors of omission or commission in collection, recording or entry. We evaluated for possible conflicts related to oxygenation variables at the pre-ductal or post-ductal site in the lowest Pre-O 2 SAT groups and found only a small cohort with possible conflict. Despite this potential conflict, we did not find a difference in repair rate, ECMO use or survival outcome when compared with the overall groups or the subgroups without potential conflict.
Conclusion
In conclusion, a reported highest Pre-O 2 SAT <85% in the first 24 h of life was not uniformly fatal. An aggressive approach to this group of infants, including operative repair, was associated with a survival rate of 44%. Survival of infants with a highest Pre-O 2 SAT <85% was associated with high ECMO use and prolonged hospitalization. Limiting intervention for CDH infants to only those infants with a higher pre-ductal saturation value may result in unnecessary deaths. Currently available parameters for assessing the severity of pulmonary hypoplasia are limited in their predictive abilities. 
